3-Hydroxyphencyclidine (3-HPC), a breakdown product of phencyclidine (PCP), is growing attracting clinical attention due to limited evidence suggesting unique biological characteristics. Preliminary research indicate https://www.pinterest.com/pin/1140888518124046392/